1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Glenmark Pharmaceuticals Ltd. Live Share Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Incorporated in 1977, Glenmark Pharmaceuticals is engaged in the business of development, manufacturing and marketing of pharmaceutical products. The company products in key therapeutic areas includes dermatology, respiratory, oncology, cardiology, d...

Read More
2226.10 6.90 (0.31%)
New 52W High in past week
1.7M
NSE+BSE Volume
High vol.+gain this week

NSE 15 Jul, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Analyst Buy
Motilal Oswal retains 'Buy' call on Glenmark Pharma, expects a revenue CAGR of 10.6% over FY26-27 See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
70.0 / 100
Valuation Score
Mid Valuation
34.8 / 100
Momentum Score
Technically Moderately Bullish
68.5 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
1,916
1Yr Price target downside is -14%
12 analysts

24

S

9

W

4

O

1

T

SWOT Analysis

Glenmark Pharma Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..
Is Glenmark Pharmaceuticals Ltd. worth buying?
569 Votes:
Buy 79.26%
Sell 13.71%
Hold 7.03%
BUY
SELL
HOLD